The treatment paradigm for prostate cancer patients with biochemical recurrence: Paul Nguyen, MD

Paul Nguyen, MD, Professor of Radiation Oncology at Harvard Medical School share his thoughts on the management of patients with a rising PSA post-RP and the utility of genomics in this setting